Welcome! You are visiting the MyeloRx web site.
Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Lead Compounds - MRx102
A lipophilic prodrug of a natural product
Intellectual property exclusively licensed to MyeloRx
Manufactured via a three step synthesis from a natural product
All rights reserved
Powered by
Microsoft Office Live Small Business